Related Experiment Videos

Tumour stimulating effects of recombinant human interleukin-6

C Ravoet, J DeGrève, K Vandewoude

Lancet (London, England)

|December 3, 1994

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Randomized phase II BGOG/ENGOT-cx1 study of paclitaxel-carboplatin with or without nintedanib in first-line recurrent or advanced cervical cancer.

Gynecologic oncology·2023

Homologous recombination repair deficiency (HRD) testing in newly diagnosed advanced-stage epithelial ovarian cancer: A Belgian expert opinion.

Facts, views & vision in ObGyn·2022

Treatment algorithm in patients with ovarian cancer.

Facts, views & vision in ObGyn·2020

A radical approach to achieve complete cytoreductive surgery improve survival of patients with advanced ovarian cancer.

Journal of visceral surgery·2019

Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

[Immune checkpoint inhibitors (antibodies to PD1 and PD-L1), a new therapeutic weapon against non-small cell bronchial carcinoma].

Revue des maladies respiratoires·2018

See all related articles